Prognostic Role of Methylation Status of theMGMTPromoter Determined Quantitatively by Pyrosequencing in Glioblastoma Patients
Authors:
Open Access
- 1 January 2016
- journal article
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 59 (1) , 26-36
Abstract
Kim DC, et al. J Korean Neurosurg Soc. 2016 Jan;59(1):26-36. http://dx.doi.org/10.3340/jkns.2016.59.1.26Keywords
This publication has 20 references indexed in Scilit:
- A Consideration ofMGMTGene Promotor Methylation Analysis for Glioblastoma Using Methylation-Specific Polymerase Chain Reaction and PyrosequencingThe Korean Journal of Pathology, 2011
- DNA methylation in glioblastoma: impact on gene expression and clinical outcomeBMC Genomics, 2010
- Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapyBritish Journal of Cancer, 2009
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Validation of Real-Time Methylation-Specific PCR to Determine O6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation in GliomaThe Journal of Molecular Diagnostics, 2008
- O6-Methylguanine-DNA methyltransferase inactivation and chemotherapyBritish Medical Bulletin, 2008
- Optimization of Quantitative MGMT Promoter Methylation Analysis Using Pyrosequencing and Combined Bisulfite Restriction AnalysisThe Journal of Molecular Diagnostics, 2007
- Receiver Operating Characteristic AnalysisAcademic Radiology, 2005
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaNew England Journal of Medicine, 2005
- Inactivation of the DNA-Repair GeneMGMTand the Clinical Response of Gliomas to Alkylating AgentsNew England Journal of Medicine, 2000